Although we observed a significant association between strong cytoplasmic Nrf2 expression in HCC with decreased OS and EMT-related marker expression, other clinicopathological factors such as proliferative activity were not significantly influenced by Nrf2 expression status. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.